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Letters
Stomach cancer incidence among males in
 
Golestan province, Iran
 
Cancer is the third most common cause of death in 
Iran and annually 30000 of Iranian die due to cancer.1 
We evaluated province-specific estimates of incidence 
of stomach cancer in men in Golestan province of 
Iran in 2004. 
Golestan province is located in north of Iran, in 
the south east of Caspian Sea. Stomach cancer data 
were identified and collected through the 18 Pathol-
ogy Laboratory centers, where male populations are 
referred. Using a structured questionnaire, trained per-
sonnel conducted in-person interviews to collect in-
formation on stomach cancer. Newly diagnosed cases 
which were detected by histologic or cytological 
examinations, were sent to the Cancer Registry Of-
fice of the province and to the registry unit in the 
Health Deputy. Age-specific rates, annual age-adjusted 
rates (ASRs) per 100,000 person-years were calcu-
lated using the direct methods of standardization to 
the world population. 
Four hundred and nine patients with cancer from 
all sites were seen in 2004; 56 (13.7%) of them had 
stomach cancer. The pathologic diagnosis in these 
cases was adenocarcinoma (44, 10.8%), carcinoma 
(8, 2.0%), and one each of undifferentiated carci-
noma, mucinous adenocarcinoma, signet ring cell car-
cinoma and malignant lymphoma. The overall stom-
ach cancer incidence was 11.23/100000 persons. The 
highest stomach cancer incidence was in age range 
80-84 years and was lowest in age range 40-44 years. 
Stomach cancer was the second (after skin cancer) 
common cancer among males. 
Comparison of the ASR for stomach cancer (age 
specific) among males in Golestan province with those 
of stomach cancer worldwide show that the Golestan 
province is one of the high-risk areas. The incidence 
of stomach cancer in Golestan province is lower when 
compared with cancer registry in other countries such 
as Japan in 1994 (ASR: 66.6/100,000 and in age 80-
84 ASR: 701.1/100,000 population)2 and China in 2005 
(ASR: 37.1/100000 and in age 75+ ASR: 261.2/100,000 
populations.3 
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Octreotide in congenital chylous ascites an 
avoid requirement of total parenteral nutrition 
Congenital chylous ascites is a rare condition 
characterized by the accumulation of triglyceride rich 
milky fluid (chyle) in the peritoneum cavity. 
Conservative management includes medium chain 
triglyceride (MCT) -based diet, total parenteral nutrition 
(TPN), repeated paracentesis and octreotide. Surgery 
is used in cases refractory to medical management.1 
TPN and surgery require expertise and are associated 
with significant morbidity and mortality. Octreotide, 
a somatostatin analogue, has been tried for the 
management of this condition. We report a case of 
congenital chylous ascites where use of octreotide 
avoided the requirement of TPN. 
A 6-month-old girl born to parents of non consanguin-
eous marriage was referred with complaint of gradual dis-
tension of abdomen since the age of 3 months. Her weight 
(3.5 Kg) and length (50 cms) were both below 5th percen-
tile of CDC 2000 growth standards. On examination, she 
had tense ascites, with umbilical and bilateral inguinal her-
niae; there was no edema. Ultrasonograpy of the abdomen 
showed presence of ascites; there was no other abnormal-
ity. 
Abdominal paracentesis revealed thick milky ascitic 
fluid; examination of ascitic fluid showed triglyceride con-
tent of 1895 mg/dL, cholesterol 58.8 mg/dL, protein 1.83 
g/dL and total cell count of 20 cells/mm3 (50% mononuclear 
cells, 50% mesothelial cells). Liver function tests and other 
routine investigations were within normal limits. 
Lymphoscintigraphy showed patent thoracic duct with no 
leak. 
Patient was started on MCT based diet with subcuta-
neous octreotide in the dose of 5 mcg/Kg twice daily, with 
a subsequent plan for TPN if the ascites did not respond. 
The baby was allowed to breast feed. Weight and abdomi-
nal girth were measured daily. The abdominal girth reduced 
from 40 cms to 31 cms over 10 days. The umbilical and 
inguinal herniae also decreased in size. Octreotide was 
stopped, and the child was discharged with advice to con-
tinue the MCT-based diet. Surgical correction of inguinal 
hernia was planned on follow up. During follow-up at 15 
days and 1 month, the child was doing well and there was 
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